COVID-19: Human Epidemiology and Response to SARS-CoV-2
Public ClinicalTrials.gov record NCT04375761. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Human Epidemiology and Response to SARS-CoV-2 (DAIT-COVID-19-001)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The human disease caused by SARS-CoV-2 is called COVID-19. In most cases, COVID-19 presents as a mild to moderate respiratory illness. But it can also be more severe and even lead to death. The purpose of this study is to: * Determine the prevalence of SARS-CoV-2 carrier status over time in children and parents * Determine the prevalence of antibody development over time in children and parents * Compare carrier status and antibody development for children with asthma and/or other atopic conditions (e.g. eczema) versus children without asthma and/or other atopic conditions * Investigate the presence of SARS-CoV-2 exposure in historical samples from enrolled participants
Study identification
- NCT ID
- NCT04375761
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 5,599 participants
Conditions and interventions
Conditions
Interventions
- Collection of Biological Samples Procedure
- Symptom and Exposure Surveys Procedure
Procedure
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2020
- Primary completion
- Mar 28, 2021
- Completion
- Mar 28, 2021
- Last update posted
- Aug 5, 2025
2020 – 2021
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital Colorado: Inner City Asthma Consortium (ICAC) Site | Aurora | Colorado | 80045 | — |
| Children's Hospital Colorado: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages (OMEGA) Site | Aurora | Colorado | 80045 | — |
| Children's National Medical Center: Inner City Asthma Consortium (ICAC) Site | Washington D.C. | District of Columbia | 20010 | — |
| Ann & Robert H. Lurie Children's Hospital of Chicago: Food Allergy Outcomes Related to White and African American Racial Differences (FORWARD) and Improving Technology-Assisted Recording of Asthma Control in Children (iTRACC) Site | Chicago | Illinois | 60611 | — |
| Massachusetts General Hospital:Childhood Microbiome (CHIME) and Wheezing Index (WIND) Site | Boston | Massachusetts | 02114 | — |
| Boston Children's Hospital: School Inner-City Asthma Study (SICAS-2), Environmental Assessment of Sleep in Youth (EASY), Severe Asthma Research Program (SARP) and Preventing Asthma in High Risk Kids (PARK) Site | Boston | Massachusetts | 02115 | — |
| Boston Medical Center: Inner City Asthma Consortium (ICAC) Site | Boston | Massachusetts | 02118 | — |
| Henry Ford Health System: Childhood Allergy Study (CAS) Site | Detroit | Michigan | 48202 | — |
| Henry Ford Health System: Inner City Asthma Consortium (ICAC) Site | Detroit | Michigan | 48202 | — |
| Henry Ford Health System: Microbes, Asthma, Allergy and Pets (MAAP) and Wayne County Health, Environment, Allergy, and Asthma Longitudinal Study (WHEALS) Site | Detroit | Michigan | 48202 | — |
| St. Louis Children's Hospital: Inner City Asthma Consortium (ICAC) Site | St Louis | Missouri | 63110 | — |
| Columbia University Medical Center: Inner City Asthma Consortium (ICAC) Site | New York | New York | 10032 | — |
| Cincinnati Children's Hospital Medical Center: Greater Cincinnati Pediatric Clinic Repository (GCPCR) and Mechanisms of Progression of Atopic Dermatitis to Asthma in Children (MPAACH) Site | Cincinnati | Ohio | 45229 | — |
| Cincinnati Children's Hospital Medical Center: Inner City Asthma Consortium (ICAC) Site | Cincinnati | Ohio | 45229 | — |
| Cincinnati Children's Hospital Medical Center: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages (OMEGA) Site | Cincinnati | Ohio | 45229 | — |
| Cincinnati Children's Hospital Medical Center:Cincinnati Childhood Allergy & Air Pollution Study (CCAAPS) Site | Cincinnati | Ohio | 45229 | — |
| Vanderbilt University Medical Center: Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE) Site | Nashville | Tennessee | 37232 | — |
| University of Texas Southwestern Medical Center: Inner City Asthma Consortium (ICAC) Site | Dallas | Texas | 75390 | — |
| University of Wisconsin Hospital and Clinics: Childhood Origins of Asthma (COAST) Site | Madison | Wisconsin | 53792 | — |
| University of Wisconsin Hospital and Clinics: Wisconsin Infant Study Cohort (WISC) Site | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04375761, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 5, 2025 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04375761 live on ClinicalTrials.gov.